Clinical trials
Active, not recruiting Phase 1 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ali Rezai | 1 |
| Baylor College of Medicine | 1 |
| Boston University | 1 |
| Mark Tuszynski | 1 |
| Mclean Hospital | 1 |
| Medical University of South Carolina | 1 |
| National University Hospital, Singapore | 1 |
| Novartis Pharmaceuticals | 1 |
| Onward Health, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 9 |
| Alzheimer Disease | 6 |
| Dementia | 3 |
| Alcoholism | 1 |
| Anxiety Disorders | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Memory Disorders | 1 |
| Nervous System Diseases | 1 |
| Neurocognitive Disorders | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.